Sweet scent for CF sufferers

A simple sugar used in inhalers could prevent the onset of bacterial infections in cystic fibrosis (CF) sufferers. Bacterial infections in CF sufferers occur because the level of salt concentration in the surface airway liquid is too high, preventing the production of an effective immune response to the invading bacteria. In a study published in the 10 October issue of PNAS, a team from the University of Iowa, USA, found that a sugar called xylitol could be used to lower the salt concentration i

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

A simple sugar used in inhalers could prevent the onset of bacterial infections in cystic fibrosis (CF) sufferers. Bacterial infections in CF sufferers occur because the level of salt concentration in the surface airway liquid is too high, preventing the production of an effective immune response to the invading bacteria. In a study published in the 10 October issue of PNAS, a team from the University of Iowa, USA, found that a sugar called xylitol could be used to lower the salt concentration in the airways. Xylitol is not used by airway bacteria, so it could enhance the ability of the immune system to kill bacteria without promoting bacterial growth. A nasal spray containing the sugar was tested on a dozen volunteers and it significantly reduced the number of nasal bacteria detected. Dr Michael Walsh commented: "The hope is that this could help prevent, or at least delay, the onset ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform